Cotiviti Announces Secondary Public Offering

Cotiviti Holdings, Inc. (NYSE:COTV), a leading payment accuracy provider to the healthcare and retail industries, ("Cotiviti" or the "Company") today announced that certain stockholders of the Company (the "Selling Stockholders") intend to offer 10,000,000 shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), in an underwritten public offering. In addition, the underwriters have been granted a 30-day option to purchase up to an additional 1,500,000 shares of Common Stock at the public offering price, less underwriting discounts and commissions. The offering consists entirely of secondary shares to be sold by the Selling Stockholders. The Selling Stockholders will receive all of the proceeds from the offering.

Goldman, Sachs & Co. and J.P. Morgan are serving as joint lead book-running managers and as representatives of the underwriters for the proposed offering. Barclays, Citigroup, Credit Suisse, Morgan Stanley and SunTrust Robinson Humphrey are acting as joint book-running managers for the proposed offering. Baird, William Blair and Leerink Partners are acting as co-managers for the proposed offering.

The offering will be made only by means of a prospectus. A copy of the preliminary prospectus relating to this offering, when available, may be obtained from any of the following sources:
  • Goldman, Sachs & Co., Attention: Prospectus Department, 200 West Street, New York, New York 10282, or via telephone: 1-866-471-2526
  • J.P. Morgan Securities LLC, Attention: Prospectus Department, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or via telephone: 1-866-803-9204

A registration statement relating to these securities has been filed with the U.S. Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy these securities be accepted prior to the time the registration statement becomes effective. Copies of the registration statement can be accessed through the Securities and Exchange Commission's website at  www.sec.gov. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Cotiviti

Cotiviti is a leading payment accuracy provider that helps healthcare payers and retailers achieve their business objectives by unlocking value from the incongruities the company discovers in the complex interactions customers have with stakeholders. Cotiviti helps clients capture over $3 billion annually through improved payment accuracy. Cotiviti provides services to eight of the top ten U.S. healthcare payers and eight of the top ten U.S. retailers.

If you liked this article you might like

Nice Recovery, But Momentum Is Missing

Nice Recovery, But Momentum Is Missing

Shark Bites: This Biotech Play Offers a Great Chart Setup

What Will Trigger the Inevitable Pullback?